Cargando…
The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma
The regulation of oncogenes by microRNA is a focus of medical research. hsa-miR-203, hsa-mir-129, hsa-miR-34a, hsa-miR-34b and hsa-miR-34c are oncosuppressive microRNAs that mediate the antitumor activity of p53. We seek to evaluate the frequencies, co-occurrence and clinical significance of the met...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408007/ https://www.ncbi.nlm.nih.gov/pubmed/36011313 http://dx.doi.org/10.3390/genes13081401 |
_version_ | 1784774502066946048 |
---|---|
author | Voropaeva, Elena N. Pospelova, Tatjana I. Orlov, Yuriy L. Churkina, Maria I. Berezina, Olga V. Gurazheva, Anna A. Ageeva, Tatjana A. Seregina, Olga B. Maksimov, Vladimir N. |
author_facet | Voropaeva, Elena N. Pospelova, Tatjana I. Orlov, Yuriy L. Churkina, Maria I. Berezina, Olga V. Gurazheva, Anna A. Ageeva, Tatjana A. Seregina, Olga B. Maksimov, Vladimir N. |
author_sort | Voropaeva, Elena N. |
collection | PubMed |
description | The regulation of oncogenes by microRNA is a focus of medical research. hsa-miR-203, hsa-mir-129, hsa-miR-34a, hsa-miR-34b and hsa-miR-34c are oncosuppressive microRNAs that mediate the antitumor activity of p53. We seek to evaluate the frequencies, co-occurrence and clinical significance of the methylation of the MIR-203, MIR-129-2, MIR-34A and MIR-34B/C genes in the tumor tissue of diffuse large B-cell lymphoma (DLBCL). The methylation was assessed in 73 samples of DLBCL and in 11 samples of lymph nodes of reactive follicular hyperplasia by Methyl-Specific Polymerase Chain Reaction (MS-PCR) and Methylation-Sensitive High-Resolution-Melting (MS-HRM) methods. All four studied genes were not methylated in the tissue of reactive lymphatic nodes. The methylation frequencies of the MIR-129-2, MIR-203, MIR-34A and MIR-34B/C genes in lymphoma tissue were 67%, 66%, 27% and 62%, respectively. Co-occurrence of MIR-203, MIR-129-2 and MIR-34B/C genes methylation, as well as the methylation of MIR-34B/C and MIR-34A pair genes were detected. The MIR-34A gene methylation was associated with increased International Prognostic Index (IPI) (p = 0.002), whereas the MIR-34B/C (p = 0.026) and MIR-203 (p = 0.011) genes’ methylation was connected with Ki-67 expression level in tumor tissue at more than 45%. We found an increasing frequency of detection of MIR-34A gene methylation in the group of patients with the Germinal-Center B-cell like (GCB-like) subtype of DLBCL (p = 0.046). There was a trend towards a decrease in the remission frequency after the first line of therapy (p = 0.060) and deterioration in overall survival (OS) (p = 0.162) in patients with DLBCL with methylation of the MIR-34A promoter. The methylation of the MIR-34A, MIR-34B/C, MIR-129-2 and MIR-203 genes in DLBCL is tumor-specific and occurs in combination. The methylation of the studied genes may be a potential differential diagnostic biomarker to distinguish between lymphoma and reactive lymph nodes, while its independent predictive value has not been confirmed yet. |
format | Online Article Text |
id | pubmed-9408007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94080072022-08-26 The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma Voropaeva, Elena N. Pospelova, Tatjana I. Orlov, Yuriy L. Churkina, Maria I. Berezina, Olga V. Gurazheva, Anna A. Ageeva, Tatjana A. Seregina, Olga B. Maksimov, Vladimir N. Genes (Basel) Article The regulation of oncogenes by microRNA is a focus of medical research. hsa-miR-203, hsa-mir-129, hsa-miR-34a, hsa-miR-34b and hsa-miR-34c are oncosuppressive microRNAs that mediate the antitumor activity of p53. We seek to evaluate the frequencies, co-occurrence and clinical significance of the methylation of the MIR-203, MIR-129-2, MIR-34A and MIR-34B/C genes in the tumor tissue of diffuse large B-cell lymphoma (DLBCL). The methylation was assessed in 73 samples of DLBCL and in 11 samples of lymph nodes of reactive follicular hyperplasia by Methyl-Specific Polymerase Chain Reaction (MS-PCR) and Methylation-Sensitive High-Resolution-Melting (MS-HRM) methods. All four studied genes were not methylated in the tissue of reactive lymphatic nodes. The methylation frequencies of the MIR-129-2, MIR-203, MIR-34A and MIR-34B/C genes in lymphoma tissue were 67%, 66%, 27% and 62%, respectively. Co-occurrence of MIR-203, MIR-129-2 and MIR-34B/C genes methylation, as well as the methylation of MIR-34B/C and MIR-34A pair genes were detected. The MIR-34A gene methylation was associated with increased International Prognostic Index (IPI) (p = 0.002), whereas the MIR-34B/C (p = 0.026) and MIR-203 (p = 0.011) genes’ methylation was connected with Ki-67 expression level in tumor tissue at more than 45%. We found an increasing frequency of detection of MIR-34A gene methylation in the group of patients with the Germinal-Center B-cell like (GCB-like) subtype of DLBCL (p = 0.046). There was a trend towards a decrease in the remission frequency after the first line of therapy (p = 0.060) and deterioration in overall survival (OS) (p = 0.162) in patients with DLBCL with methylation of the MIR-34A promoter. The methylation of the MIR-34A, MIR-34B/C, MIR-129-2 and MIR-203 genes in DLBCL is tumor-specific and occurs in combination. The methylation of the studied genes may be a potential differential diagnostic biomarker to distinguish between lymphoma and reactive lymph nodes, while its independent predictive value has not been confirmed yet. MDPI 2022-08-07 /pmc/articles/PMC9408007/ /pubmed/36011313 http://dx.doi.org/10.3390/genes13081401 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Voropaeva, Elena N. Pospelova, Tatjana I. Orlov, Yuriy L. Churkina, Maria I. Berezina, Olga V. Gurazheva, Anna A. Ageeva, Tatjana A. Seregina, Olga B. Maksimov, Vladimir N. The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma |
title | The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma |
title_full | The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma |
title_fullStr | The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma |
title_full_unstemmed | The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma |
title_short | The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma |
title_sort | methylation of the p53 targets the genes mir-203, mir-129-2, mir-34a and mir-34b/c in the tumor tissue of diffuse large b-cell lymphoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408007/ https://www.ncbi.nlm.nih.gov/pubmed/36011313 http://dx.doi.org/10.3390/genes13081401 |
work_keys_str_mv | AT voropaevaelenan themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT pospelovatatjanai themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT orlovyuriyl themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT churkinamariai themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT berezinaolgav themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT gurazhevaannaa themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT ageevatatjanaa themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT sereginaolgab themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT maksimovvladimirn themethylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT voropaevaelenan methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT pospelovatatjanai methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT orlovyuriyl methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT churkinamariai methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT berezinaolgav methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT gurazhevaannaa methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT ageevatatjanaa methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT sereginaolgab methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma AT maksimovvladimirn methylationofthep53targetsthegenesmir203mir1292mir34aandmir34bcinthetumortissueofdiffuselargebcelllymphoma |